FDA Approved: ADREVIEW — Supplemental Application (Medi-Physics Inc.)

View source ↗

Summary

FDA approved a supplemental application for ADREVIEW (Iobenguane I-123) from Medi-Physics Inc. to update its labeling/indications as a radiopharmaceutical imagi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma
• Pheochromocytoma

Drugs mentioned

• ADREVIEW (IOBENGUANE I-123)

Snippet

SUPPL AP for ADREVIEW (IOBENGUANE I-123)